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Edited by Masayuki MiyasakaAbstract We previously reported that daily intraperitoneal
injections of oleamide weakly inhibits the spontaneous metastasis
of BL6 cells by blocking the gap junction-mediated intercellular
communications (GJIC) of connexin 26 (Cx26). In the present
study, we tested camellia oil, olive oil and cottonseed oil which
are rich in oleamide-like oleic acid for their inhibitory potency
on Cx26-mediated GJIC and spontaneous metastasis of BL6
cells. We found that camellia oil, olive oil and cottonseed oil,
and their distillate fractions inhibited Cx26-mediated GJIC.
We also showed that daily intraperitoneal injection of camellia
oil and its distillate fractions more potently inhibited spontane-
ous lung metastasis of BL6 cells than oleamide. Moreover, a
daily oral administration of camellia oil distillate fraction eﬀec-
tively inhibited spontaneous metastasis. Notably, even camellia
Tempura-oil, a commercially available food, weakly inhibited
the spontaneous metastasis of BL6 cells. Since these oils are used
as foods and are quite safe, we propose that they could be used as
supplements to protect patients from lung metastasis of melano-
mas.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Gap junction1. Introduction
Cancer metastasis which leads to the formation of clinically
signiﬁcant secondary tumors at distant sites remains a major
challenge in the clinical management of cancer [1–3]. Human
melanoma, for example, is curable as an early stage melanoma,
but advanced metastatic melanoma frequently demonstrates
metastasis to brain, lungs, lymph nodes, and skin [4]. To devel-
op putative anti-metastatic drugs which are clinically useful, it
is essential that they inhibit spontaneous metastases but not
experimental metastases, because metastasis occurs in cancer
patients via the former mechanism rather than through the lat-
ter mechanism. Nonetheless, most anti-metastatic drugs have
been identiﬁed based on the experimental metastasis assay pri-
marily because it saves labor and time.
To understand the diﬀerences between experimental and
spontaneous metastases, two sublines of the B16 mouse mela-*Corresponding author. Fax: +81 6 6875 5192.
E-mail address: snj-0212@biken.osaka-u.ac.jp (H. Nojima).
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mental models [5]. Both sublines show eﬃcient lung
metastasis after intravenous injection (experimental metastasis
assay) but only the BL6 cells will provoke lung metastasis
when the cells are implanted into the mouse footpad (sponta-
neous metastasis assay). We reasoned previously that the dif-
ferences in gene expression between these two sublines may
be small, but would be highly relevant to the mechanism of
spontaneous metastasis. Thus, we developed a new compre-
hensive cDNA library subtraction technique [6,7] which we
used to isolate genes that are upregulated in BL6 cells com-
pared to F10 cells [8–11]. Among the genes isolated, we found
that the expression of the connexin 26 (Cx26; GJB2) gene is
upregulated in BL6 cells. Further, we demonstrated that ecto-
pic over-expression of the Cx26 gene in F10 cells caused them
to spontaneously metastasize at levels similar to BL6 cells,
indicating that upregulation of Cx26 is responsible for the high
spontaneous metastasis of BL6 cells [8]. Moreover, we found
that spontaneous metastasis of BL6 cells could be proportion-
ally blocked by increasing the level of an ectopically expressed
dominant negative form of Cx26 introduced into these cells [8].
Thus, we could demonstrate that the enhanced expression of
Cx26 is responsible for the enhanced spontaneous metastasis
of BL6 cells.
The Cx26 gene belongs to a multigene family that is com-
posed of 21 highly conserved genes in the human genome,
and the connexin proteins encoded by these genes constitute
the transmembrane channels called gap junctions which allow
the propagation of action potentials and mediate the transfer
of small molecules between the cytoplasm of adjacent cells in
the body [12,13]. Since intercellular communication in many
organs is maintained through gap junction intercellular com-
munication (GJIC), which may regulate cell growth and diﬀer-
entiation, the Cx26 knockout mice has an embryonic lethal
phenotype [14]. In humans, germline missense mutations in
the Cx26 gene cause hereditary non-syndromic sensorineural
deafness, as well as syndromic forms of hearing loss [13,15].
A crucial role of Cx26 in auditory function was also demon-
strated in the mouse by preparation of a targeted ablation of
Cx26 expression in the inner ear epithelial gap junction net-
work and by demonstrating hearing impairment in such mice
[16]. The loss of Cx26 in mammary epithelium before puberty
resulted in abrogated lobulo-alveolar development and in-
creased cell death during pregnancy, indicating a critical role
for Cx26 during the early stages of pregnancy [17]. A proposed
role for Cx26 as a tumor suppressor [18,19] is controversial be-
cause neither hyperproliferation nor hyperplasia was observedblished by Elsevier B.V. All rights reserved.
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nancies [17]. We proposed previously that Cx26 has a novel
function; it promotes the spontaneous metastasis of melanoma
cells when its expression is increased [8].
The non-selective connexin inhibitor, the sleep-inducing
lipid-amide hormone oleamide, and its derivatives, are useful
for the study of the molecular function of connexins [20]. Olea-
mide and its derivatives may be clinically useful as hypnotics
for the induction of sleep, because oleamide can induce analge-
sia and hypothermia, but does not cause catalepsy; however,
oleamide was anxiolytic in a social interaction test and elevated
plus-maze without eﬀect on motor function [21]. We recently
showed that oleamide derivatives, MI-18 [22] and MI-22 [23],
may also be clinically useful because it inhibited the GJIC
mediated spontaneous metastasis of B16 mouse melanoma
cells by inhibiting Cx26. In these reports, we could show the
evidence that directly connects the inhibitions of Cx26-medi-
ated GJIC to their anti-metastatic activity. To make MI-18
and MI-22 clinically available, however, laborious and time-
consuming clinical testing must be conducted. To alleviate this
diﬃculty, we herein report that camellia oil and its distillate
fractions, which are rich in oleamide-like oleic acid, also exhi-
bit inhibitory eﬀects on the spontaneous metastasis of BL6
cells via inhibition of Cx26-mediated GJIC. Since camellia
oil is used as a food and is safe when administered orally,
our data suggest that these oils may be used as supplements
to protect patients from lung metastases of melanomas.2. Materials and methods
2.1. Cells and culture
BL6 melanoma cells were kindly provided by Professor I.J. Fidler
(The University of Texas, Houston, TX, USA). HeLa-Cx26 and
-Cx43, HeLa subclones that stably express rat Cx26 or Cx43, were gifts
from Dr. H. Yamasaki. All cells were maintained in Dulbecco’s mod-
iﬁed Eagle’s medium (DMEM) with 10% fetal calf serum (FCS).
2.2. Fractionation of oils
Extra-virgin olive oil, camellia oil (from Camellia japonica) and win-
terized cottonseed oil were purchased from Shodoshima Olive (Kag-
awa, Japan), Horiuchi Oil Mill (Kumamoto, Japan) and Okamura
Oil Mill (Osaka, Japan), respectively. Camellia Tempura-oil (from
Camellia japonica) was purchased from Oshima Tsubaki Co., (Tokyo,
Japan). Each distillation step with 12 kg of olive oil or 1.2 kg of camel-
lia oil was conducted at constant pressure (0.01–0.02 mbar) using a
falling ﬁlm molecular distiller (Kobelco Eco-solutions Co. Ltd. Kobe,
Japan). The ﬂow rate was 150 ml/h and the molecular distillation tem-
perature (evaporator temperature) was about 250 C. This process
yielded 2.9% (342 g/12 kg) olive oil distillate (Od) and 11.6 g of olive
oil residue (Or). The Od was left at 8 C for at least 24–48 h, and
was centrifuged at 10,000 · g for 5 min at 20 C to separate olive oil
distillate supernatant (Od) and sediment (Or) prior to the experiments.
Similarly, the distillation process yielded 3.5% (42 g/1.2 kg) camellia oil
distillate (CmD) and 1.15 kg of camellia oil residue (CmR). CmD was
left at 8 C for 48 h, after which 1.7 g of crystallized oil (CmCD: camel-
lia oil crystalline distillate) was separated from camellia oil distillate
(CmFD: camellia oil ﬁltered distillate) by a 7 lm ﬁlter (No. 5A ﬁlter
paper of Kiriyama, Japan). Olive oil crystalline distillate (OoCD)
and winterized cottonseed oil (Cs) were similarly obtained to use as
controls.
2.3. Evaluation of the GJIC capacity
To evaluate GJIC capacity, we performed a Lucifer yellow (LY,
Sigma) dye transfer assay using HeLa-Cx26 cells. Brieﬂy, we injected
a 5% LY solution (dissolved in 0.33 M LiCl, 0.03% Brij35) with a
hand-made glass needle into a cultured HeLa-Cx26 cell using an
Eppendorf Femtojet microinjector (Hamburg, Germany). After5 min, the numbers of HeLa cells into which the LY dye had spread
was counted under a ﬂuorescence microscope. Experiments were re-
peated three times, with similar results. Counting was performed for
50 donor cells per oil group. Donors were single cells that were at least
20 cells away from other donor cells. The Fisher exact test was used to
determine signiﬁcant diﬀerences in the GJIC data. The mean and stan-
dard deviation (S.D.) of the counts were calculated for assays using
each agent and expressed as GJIC scores.
Oil samples were dissolved in DMSO to make 100 mg/ml solutions,
except for the olive oil distillate (80 mg/ml) and olive oil distillate sed-
iment (50 mg/ml). To assess the inhibitory eﬀects of oil samples on
Cx26-mediated GJIC, these oil samples were added to the culture
medium (10 ll per 1 ml of medium in 35-mm tissue culture dish) of
HeLa-Cx26 cells 24 h before the dye transfer assay to achieve a ﬁnal
concentration of 1% (v/v). Thus, the ﬁnal concentrations per ml med-
ium were; DMSO (ca. 10 ll/ml), olive oil distillate (0.8 mg/ml), olive oil
distillate sediment (0.5 mg/ml) and other oil samples (1 mg/ml).
The cytotoxicity of these oils and fractionated oil distillates was also
assessed by incubation of the cultured HeLa cells in their presence for
24 h. Then, the viability of the cells was determined by crystal violet
staining.
2.4. Mouse experiments
The spontaneous metastasis assay was performed as described previ-
ously [8]. Brieﬂy, 2.5 · 105 BL6 cells were injected subcutaneously into
one footpad of a 4-week-old male C57BL/6 mouse. Olive oil (10 ml per
kg of mouse), camellia oil (10 ml per kg of mouse), cottonseed oil
(10 ml per kg of mouse), CmFD (500 mg per kg of mouse in olive
oil) or CmCD (300 mg per kg of mouse in olive oil) was injected intra-
peritoneally once a day, respectively, starting the day after the BL6
cells were injected into the footpad. This continued until the mice were
sacriﬁced. The growth of the primary tumor was monitored by measur-
ing its diameter every day. When tumors reached a diameter of 7 mm,
approximately 3–5 weeks later depending on the individual mouse, the
tumor-bearing legs were amputated along with the right popliteal
lymph node. After an additional 28 days, the mice were sacriﬁced
and autopsied to count metastatic colonies in the bilateral lungs.
CmCD (500 mg per kg of mouse) or camellia Tempura-oil (10 ml per
kg of mouse), respectively, was daily administered orally by gavage
using a gastric sonde. The Aspin–Welch test was used to determine sig-
niﬁcant diﬀerences between the metastasis data.3. Results
3.1. Oil fractions inhibited Cx26-mediated gap junction
intercellular communication
Previously, we found that oleamide, a derivative of oleic acid
and an endogenous sleep-inducing lipid hormone, weakly
inhibited the spontaneous metastasis of BL6 cells by blocking
gap junction-mediated intercellular communications (GJIC)
through connexin 26 (Cx26). During these experiments, we no-
ticed that even olive oil rich in oleic acid showed similar inhib-
itory eﬀects, although the level of inhibition was very weak. To
determine whether this phenomenon has any biological signif-
icance, we examined the inhibitory eﬀects of olive oil and
camellia oil, both rich in oleic acid (78%, see Table S1),
and their fractionated components, on the inhibition of
Cx26-mediated GJIC. We also tested cottonseed oil, which is
rich in linoleic acid (47.1%) and has only a low level of oleic
acid (17.8%) (Table S1), as a control.
Using a Lucifer Yellow dye transfer assay with HeLa-Cx26
cells, we ﬁrst tested olive oil from a Japanese company (Oo)
and found that it had a very weak inhibitory eﬀect on Cx26-
mediated GJIC (Fig. 1A). Olive oil from Sigma (Oos) also
showed a similar weak inhibitory eﬀect. Then, we subjected
the Oo to distillation using a falling ﬁlm molecular distiller
and obtained distillate (Od) and residue (Or). We found that
Od exhibited 40% inhibition compared to non-treated con-
Fig. 1. Inhibitory eﬀect of olive oil, camellia oil, cottonseed oil, and
their distillate fractions on Cx26-mediated GJIC. (A) Fractions of
olive oil were assayed and compared with camellia oil and cottonseed
oil in a Lucifer Yellow dye transfer assay using HeLa cells expressing
Cx26 protein. (B) Fractions of camellia oil were compared with the
fractions of olive oil and cottonseed oil. Evaluation of the GJIC
capacity was conducted by Lucifer yellow dye transfer assay using
HeLa cells expressing Cx26 protein. Inhibitory eﬀects were compared
to the DMSO solvent-treated control (Ct). The mean values are shown
by bar graphs with error bars indicating the standard deviation of 50
independently performed dye transfer assays. Abbreviations used are
as follows. Ct: control, Oo: olive oil, Od: Oo distillate, Or: Oo residue
Osp: Oo distillate supernatant, Osd: Oo distillate sediment Cm:
camellia oil, Cs: cottonseed oil, Oos: olive oil of Sigma.
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compound may have been concentrated in the Od fraction.
We next fractionated Od by leaving it at 8 C for 24–48 h to
make sediment (Osd), which was then separated from the
supernatant (Osp) by centrifugation, and found that Osd
showed about 50% inhibition of Cx26-mediated GJIC com-
pared to the non-treated control (Fig. 1A).
In parallel with these experiments, we tested camellia oil
(Cm) and cottonseed oil (Cs), and found that camellia oil
showed more than 40% inhibition even before any fraction-
ation. The result suggests that camellia oil may be more useful
than olive oil as a source of metastasis inhibitors. We fraction-
ated Cm using a falling ﬁlm molecular distiller and obtained
camellia oil distillate (CmD) and residue (CmR), and foundthat CmR showed slightly stronger inhibition than CmD
(Fig. 1B). We next fractionated CmR by leaving it at 8 C
for 48 h. The crystals were then separated by ﬁltration to
obtain camellia oil crystalline distillate (CmCD) and ﬁltered
distillate (CmFD). Olive oil crystalline distillate (OoCD) and
cottonseed oil (Cs) were similarly obtained for use as controls.
We found that CmCD and OoCD displayed the strongest inhi-
bition (50%) of Cx26-mediated GJIC (Fig. 1B). CmFD,
CsCD and CmR showed slightly weaker levels of inhibition
(42–46%), but these levels were approximately one half the
level of inhibition produced by MI-18, an oleamide derivative
and a potent inhibitor of Cx26-mediated GJIC that we previ-
ously identiﬁed [23]. We conﬁrmed that these oils and fraction-
ated oils were not cytotoxic by monitoring mortality after
adding them to the medium of cultured cells (data not shown).3.2. Camellia oil inhibits the spontaneous metastasis of BL6 cells
We previously showed that an oleamide derivative MI-18
[22] and MI-22 [23] potently blocked the spontaneous metasta-
sis of BL6 melanoma cells by inhibiting Cx26-mediated GJIC.
Here, we examined whether olive oil, camellia oil and cotton-
seed oil also inhibit BL6 cells from spontaneously metastasiz-
ing to the lung using the spontaneous metastasis assay (see
Section 2). Oils were separately injected intraperitoneally every
day, starting one day after the injection of the mouse footpad
with the BL6 melanoma cells. As shown in Fig. 2A, olive oil
alone showed only a slight, but not statistically signiﬁcant inhi-
bition of spontaneous metastasis compared to saline-treated
controls (Sa). Fractions of olive oil (Od or Or) also showed
very weak inhibition of the spontaneous metastasis of BL6
cells (Fig. 2B). However, camellia oil (Cm) displayed about
37% inhibition compared to saline-treated controls, which
was statistically signiﬁcant as determined by the Aspin–Welch
test (P < 0.05). Five mice injected with camellia oil showed no
metastatic colonies in the lung, two showed less than 20 colo-
nies, and even the three mice with the most metastases carried
less than 80 metastatic colonies in the lung (Fig. 2C). This is in
contrast to the ﬁve saline-injected mice which carried >100
metastatic colonies in the lung. Notably, 8 out of 10 mice
injected with cottonseed oil showed no metastatic colonies in
the lung. The average value was not statistically signiﬁcant
(Aspin–Welch test) because two mice showed >100 metastatic
colonies in the lung.3.3. Camellia oil fractions inhibit the spontaneous metastasis of
BL6 cells
We next examined whether fractionated camellia oil had any
inhibitory eﬀect on the spontaneous metastasis of BL6 cells.
Camellia oil ﬁltered distillate (CmFD) and crystalline distillate
(CmCD) which inhibited Cx26-mediated GJIC, as shown
above, were separately injected intraperitoneally into mice
every day, and the spontaneous metastasis assay using BL6
cells was conducted. As shown in Fig. 3A, CmFD injected
mice showed a 52% inhibition of spontaneous metastasis com-
pared to saline-injected mice. In contrast, CmCD showed al-
most no inhibitory eﬀect. CmCD was probably not properly
absorbed into the bodies of the mice due to its crystalline nat-
ure; crystalline distillate was found in the peritoneal cavity
when mice were sacriﬁced (see Section 4). Actually, when
CmCD was orally administered by gavage using a gastric
sonde, which allowed mice to absorb it eﬀectively, about
Fig. 3. Inhibitory eﬀect of distilled fractions of camellia oil on the
spontaneous metastasis of BL6 melanoma cells to the lung. (A) Daily
intraperitoneal (i.p.) injection of camellia oil ﬁltered distillate (CmFD)
and oral administration of camellia oil crystalline distillate (CmCD)
eﬀectively inhibit the spontaneous metastasis of BL6 cells compared to
saline-treated (Sa) controls. In contrast, no apparent inhibition was
observed by i.p. injection of CmCD. Ten mice were examined for each
group. *P < 0.05 by the Aspin–Welch test when compared to the Sa
(i.p.) control group. (B) Bar graphs show the number of colonies of
BL6 cells which metastasized to the lung of each mouse in each
experimental group. Mice from each group (ID: 1–10) are arranged
from left to right in order of increasing numbers of metastasized
colonies. (C) Mortality of mice due to the injection of the indicated
agents after amputation. The greater survival rates of the CmCD-p.o.
(·) and CmFD-i.p. (h) treated mice as compared to saline (}) and
CmCD-i.p. (n) treated mice are probably the result of eﬀective
inhibition of the metastasis of BL6 cells by these fractions, which
enabled the mice to be healthier. (D) Photos of the lungs removed from
the autopsied mice. The lungs of all saline-treated (i.p.), CmFD-treated
(i.p.) and CmCD-treated (p.o.) mice are shown.
Fig. 2. Inhibitory eﬀect of olive oil, camellia oil and cottonseed oil on
the spontaneous metastasis of BL6 melanoma cells to the lung. (A)
Daily intraperitoneal injection of olive oil (Oo) weakly inhibits the
spontaneous metastasis of BL6 cells as compared to non-treated (Nt)
or saline-treated (Sa) controls. Fifteen mice were examined for each
group. (B) Camellia oil (Cm) and cottonseed oil (Cs) inhibit the
spontaneous metastasis of BL6 cells more potently than olive oil
distillate (Od) and olive oil residue (Or). Each group contained 10 mice
except for the Od fraction which contained 15 mice (denoted by #).
*P < 0.05 by the Aspin–Welch test when compared to the value
obtained from the Sa control group. (C) Bar graphs show the number
of colonies of BL6 cells which metastasized to the lung of each mouse
in each experimental group. Mice from each group (ID: 1–10) are
arranged from left to right in order of increasing numbers of
metastasized colonies.
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this result was statistically signiﬁcant (P < 0.05). Notably, only
1 of the 10 mice that were orally administered with CmCD
showed >100 metastatic colonies in the lung (Fig. 3B), and 7
of the 10 mice that were intraperitoneally injected by CmFD
showed almost no metastatic colonies in the lung (Fig. 3B).
To assess whether these camellia oil fractions caused any
mortality, we monitored the mice for four weeks after amputa-
tion of the tumor-bearing leg, while continuing the daily
administration. As expected, we found that these oil fractions
appear to be quite safe since none of the mice died in the 12
days following the amputation (Fig. 3C). Even 25 days after
the amputation, 9 of the 10 CmFD (i.p.)-treated mice and 9
of the 10 CmCD (p.o.)-treated mice survived. The death of
the two mice appeared to be due to the metastasis of BL6
rather than to toxicity of CmFD or CmCD. In contrast, the
survival rate of the saline-treated mice was only 50%, and most
died due to the metastasis of BL6. The greater survival rate of
the CmFD (i.p.)- and CmCD (p.o.)-treated mice is probably
because CmFD or CmCD eﬀectively inhibited metastases,
thereby preventing their premature death.
In Fig. 3D, we present photo-images of all the lungs from
the saline-treated control mice, the CmFD (i.p.)-, and CmCD(p.o.)-treated mice. The lungs were removed at autopsy, 28
days after amputation, when the mice were sacriﬁced. While
D. Miura et al. / FEBS Letters 581 (2007) 2541–2548 2545multiple metastatic colonies were observed in the lungs from
the untreated mice, metastatic colonies were absent or reduced
in number in the lungs of mice treated with CmFD or CmCD.
3.4. Orally administered camellia Tempura-oil inhibits the
spontaneous metastasis of BL6 cells
Successful inhibition of spontaneous metastasis of BL6 cells
by oral administration with CmCD encouraged us to test
whether the commercially available camellia Tempura-oil,
which is consumed as a food, would also exhibit an inhibitory
eﬀect. Camellia Tempura-oil is also rich in oleic acid (86.1%)
and has similar fatty acid composition to that of camellia oil
described above (Table S1). To detect even small diﬀerences,
we tested 19 mice and orally administered camellia Tempura-
oil using a gastric sonde starting one day after a subcutaneous
injection of the mouse footpad with BL6 melanoma cells. As
shown in Fig. 4A, camellia Tempura-oil eﬀectively inhibited
the spontaneous metastasis of BL6 cells and camellia Tem-
pura-oil treated mice had signiﬁcantly fewer tumors (Aspin–
Welch test, P < 0.05) with only 59% the number of tumors
found in the non-treated control mice (Nt). Seven of 19 camel-
lia Tempura-oil treated mice possessed >100 metastatic colo-
nies in the lung when sacriﬁced 28 days after amputation,
while 13 of 19 Nt mice possessed >100 metastatic colonies
(Fig. 4B). Notably, 12 of 19 mice orally administered with
camellia Tempura-oil showed less than 40 metastatic coloniesFig. 4. Inhibitory eﬀect of camellia Tempura-oil on spontaneous
metastasis of BL6 melanoma cells to the lung. (A) Daily oral
administration of camellia Tempura-oil (Cm) inhibits the spontaneous
metastasis of BL6 cells as compared to non-treated (Nt) controls.
Nineteen mice were examined for each group. *P < 0.05 by the Aspin–
Welch test when compared to the value obtained from the Nt control
group. (B) Bar graphs show the number of colonies of BL6 cells which
metastasized to the lung of each mouse in each experimental group.
Mice of each group (ID: 1–19) are arranged from left to right in order
of increasing numbers of metastasized colonies. (C) Mortality of mice
during the period of oral administration of camellia Tempura-oil after
amputation. Death of mice at 28 days appears to be due to the
metastasis of BL6 cells.in the lung, suggesting an eﬀective inhibition of spontaneous
metastasis BL6 cells. As expected from a food substance,
camellia Tempura-oil is safe because none of the camellia Tem-
pura-oil treated mice died in the 22 days following the ampu-
tation (Fig. 4C), and the death of mice after 28 days appeared
to be due to the metastasis of BL6. These results suggest that
camellia Tempura-oil is clinically useful as a supplement
because it may eﬀectively inhibit the metastasis of cancer cells.4. Discussion
In our previous report, we showed that increased expression
of Cx26 is responsible for enhanced spontaneous metastasis of
mouse BL6 melanoma cells, and that ectopic expression of a
dominant negative Cx26 inhibited this spontaneous metastasis
[8]. We also showed that daily intraperitoneal injections of an
oleamide derivatives named MI-18 [22] and MI-22 [23] po-
tently blocked spontaneous metastases to the lung. MI-18
and MI-22 appears to be clinically useful because it is safe as
judged by the fact that the survival rate of the mice was nearly
100% even after seven weeks of daily injections, and that it
showed no cytotoxicity when added to cultured cells. Nonethe-
less, it may take many more years before it becomes clinically
available because clinical drug testing is usually very time con-
suming.
In the present study, we showed that camellia oil and its dis-
tillate fractions, CmFD by i.p. and CmFD by p.o., eﬀectively
inhibited the spontaneous metastasis of BL6 melanoma cells
(Figs. 2 and 3) by Cx26-mediated GJIC (Fig. 1). The reason
why CmCD by i.p. injection showed no inhibitory eﬀect was
probably due to its poor solubility to water. As described
above (Fig. 3), it might have had a much stronger inhibitory
eﬀect if it had been properly adsorbed into the body. Since oral
administration is more practical in a clinical setting than i.p.
injection, we did not further try to improve the conditions
for the i.p. injection of CmCD. Moreover, considering that
both CmFD and CmCD similarly inhibited Cx26-mediated
GJIC when properly dissolved in the culture medium
(Fig. 1B), p.o. administration of CmFD might have also inhib-
ited spontaneous metastasis, although we did not test it in this
series of experiments. Notably, even p.o. administration of
camellia Tempura-oil inhibited spontaneous metastasis
(Fig. 4). These results suggest that camellia oil and its distillate
fractions could be tested immediately as food supplements in a
clinical setting to inhibit metastasis of cancer cells because
food items generally do not require prior safety assessment.
Since the dose is low, being only about 0.2 ml of oil per mouse
(10 ml per kg of mouse) once a day, whose amount is less than
the ordinary daily food intake of mouse and thus can be easily
ingested daily, we consider that we can neglect the inﬂuence of
excess calorie intake on metastasis in our experiments.
Oral administration into the mouse stomach using a gastric
sonde is probably a good model for direct administration into
the intestine in humans. It may be preferable, therefore, to
package camellia oil in microcapsules coated with a gastric-
resistant coating, which would allow absorption only in the
intestine and not in the stomach where acid could potentially
impair the active components of camellia oil. Alternatively,
the components could be enrobed in candy which would allow
them to be easily taken and absorbed through the mucous
membrane of the mouth. Of course, the administration of
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will depend very much on the restrictions imposed by the laws
governing clinical testing in each country.
The mechanism through which MI-18 [22], MI-22 [23] or
camellia oil inhibits spontaneous metastasis of cancer cells
must at least partly be associated with the ability of these com-
pounds to interfere with cellular functions such as adhesive-
ness, motility and invasiveness. In Fig. 5, we propose a
working hypothesis to elucidate why these compounds inhibit
the spontaneous metastasis of BL6 cells via inhibition of Cx26-
mediated GJIC. We propose that BL6-type cancer cells are
invasive in vivo, because cancer cells expressing enough Cx26
are able to form tight connections with surrounding normal
cells and migrate to blood vessels from which they are trans-
ported to the target organ (Fig. 5A). In contrast, F10-type can-
cer cells do not metastasize spontaneously because they are not
invasive in vivo due to the lack Cx26. F10-type cells can metas-
tasize only if they are injected intravenously, because the
in vivo invasion step is not part of experimental metastasis
assay (Fig. 5B). MI-18, MI-22 or camellia oil may change
the ﬂuidity of the cancer cell membrane and inactivate Cx26
(Fig. 5C), thereby inhibiting the spontaneous metastasis of
BL6-type cancer cells.
The above results would be clinically meaningful only if the
overexpression of Cx26 is frequently observed in clinical sam-
ples. We previously proposed that clinical cancer cells be clas-
siﬁed into two groups; low Cx26-expressing F10-type cells that
are unable to spontaneously metastasize, and high Cx26-
expressing BL6-type cells that can potently metastasize sponta-
neously [22]. In fact, augmented Cx26 expression has been
observed in highly metastatic human melanomas [8]. Human
lung squamous cell carcinomas [24], prostate cancer [25], and
some breast cancers also show increased Cx26 expression
[26–29]. Metastasized tissues of human esophageal, pancreatic,
gastric, and colon tumors also displayed enhanced expressionFig. 5. A working hypothesis to explain the mechanism of inhibition of sponof Cx26 (our unpublished data). Moreover, patients with
Cx26-positive tumors showed a signiﬁcantly poorer prognosis
than those with Cx26-negative tumors [24,29]. Thus, increased
Cx26 expression appears to be common to highly metastatic
variants of human cancers, which suggests that camellia oil
might be useful as an anti-metastasis supplement in many cases
of human cancers.
Daily consumption of extra-virgin olive oils could be partly
responsible for the lower mortality and incidence of cancer in
the Mediterranean region, probably due to protection from
oxidative DNA damage [30]. A phenol antioxidant derived
from olive oil induced growth arrest and apoptosis in human
colon carcinoma (HT-29) cells [31]. Polyphenols from virgin
olive oil appears to play a critical role in the inhibition on pro-
liferation of human promyelocytic leukemia (HL60) cells by
inducing apoptosis and diﬀerentiation [32]. On the other hand,
diets rich in linoleic acid stimulate the metastasis of human
breast cancer cells because it is metabolized to various eicosa-
noids that may stimulate invasion and metastasis of tumor
cells [33]. In contrast, inhibitors of eicosanoid metabolism con-
vert mouse melanoma cells to a non invasive state [34]. Thus,
we cannot exclude a possibility that fatty acids and/or other
components of oils used here interfere with the production
of eicosanoids.
A role of oleic acid on GJIC regulation was reported in car-
diac myocytes [35] and cardiomyocytes [36], which may inﬂu-
ence the paracellular permeability through control of barrier
function mediated by tight junctions, and thus may regulate
metastasis [37]. Orally administered oleic acid inhibited not
only the experimental metastasis of colon carcinoma 26 cells
to the lung [38], but also the metastasis to the liver in mice
implanted intrasplenically with Lewis lung carcinoma tumors
[39]. Oleic acid can also suppress the overexpression of
HER2 (erbB-2) that plays a key role in the invasive progres-
sion and metastasis in several human cancers [40]. Our previ-taneous metastasis of BL6 cells via inhibition of Cx26-mediated GJIC.
D. Miura et al. / FEBS Letters 581 (2007) 2541–2548 2547ous data [23] suggest that unknown metabolites of oleic acids,
including oleamide derivatives, might play a role in inhibition
of Cx26-mediated GJIC, not only in the plasma membrane but
also in the intracellular membrane, and thus blocked the spon-
taneous metastasis of BL6 cells. Our results here also support
this notion because an uncharacterized component in CmCD
appear to possess more potent inhibitory eﬀect than camellia
oil itself which is highly rich in oleic acid. Although we con-
ducted a mass spectrometry (LC-MS/MS) analysis of CmCD
to identify the eﬀective component, we detected too many com-
ponents to select a speciﬁc component as a potential candidate
(Supplementary Fig. S1). Puriﬁcation of the component that
eﬀectively functions as an inhibitor of spontaneous metastasis
should be conducted in future experiments.Acknowledgements:We thank Dr. Patrick Hughes for critically reading
the manuscript and Ms. A. Fujimori for technical assistance. This
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Supplementary data associated with this article can be found,
in the online version, at doi:10.1016/j.febslet.2007.04.080.
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